Skip to content

Effect of oral vitamin D3 supplementation on biochemical factors in polycystic ovary syndrome

Effect of oral vitamin D3 supplementation on bone biochemical factors, serum magnesium and zinc in polycystic ovary syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201201043140N3
Enrollment
54
Registered
2012-01-13
Start date
2011-04-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: control group: placebo every 20 days for 60 days. Intervention 2: intervantion group: 50000 IU vitaminD3 every 20 days for 60 days.
Placebo
Treatment - Drugs

Sponsors

Student research committee
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of PCOS based on Rotterdam criteria (presence of two of the three following characteristics: 1. oligomemorreha /amenorrhea, 2. chemical or clinical finding of hyperandrogenism and 3. polycystic appearance of ovary); voluntary consent for participation in the study; female aged 18-40 years. Exclusion criteria: Other common causes of hyperandrogenemia and/or anovulation; hyperprolactinoma; congenital adrenal hyperplasia; Cushing syndrome, and virilizing ovarian or adrenal tumors; diabetes mellitus and heart, kidney and liver dysfunction; using vitamin D or Calcium supplement, metformin or insulin sensitizing drugs, corticosteroids, anticonvulsants during last 2 month or during the study; Smoking; alcohol abuse; breast feeding and pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement of bone biochemical factors. Timepoint: before and after intervention (60 days). Method of measurement: serum levels of alkaline phosphatase, calcium, phosphoruse.;Improvement of serum zinc and magnesium. Timepoint: before and after intervention (60 days). Method of measurement: serum levels of zinc and magnesium.

Secondary

MeasureTime frame
Food habits. Timepoint: before and after intervention (60 days). Method of measurement: 3 days 24h dietaty racall.;Anthropometric indicator. Timepoint: before and after intervention (60 days). Method of measurement: Body weight without shoes with calibrated scale, Standing height without shoes are measuredl. BMI was calculated with this equation: W(kg) /H(m)2.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHania Rahini

Health and Nutrition Faculty, Tabriz university of medical sciences

hania.rahimi@gmail.com+98 41 1330 4779

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026